Mega Lifesciences Public Company Limited Total Liabilities
Mega Lifesciences Public Company Limited total liabilities. Based on the latest financial reports, Mega Lifesciences Public Company Limited (MEGA) has total liabilities worth ฿5.80 Billion THB (≈ $180.89 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check MEGA asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Mega Lifesciences Public Company Limited (2010–2025)
Total liabilities of Mega Lifesciences Public Company Limited from 2010 to 2025. This chart illustrates how Mega Lifesciences Public Company Limited's total liabilities have evolved over time, based on quarterly financial data. Explore MEGA long-term investments to assets to see how much of total assets are deployed in long-term investments.
Mega Lifesciences Public Company Limited Competitors by Total Liabilities
The table below lists competitors of Mega Lifesciences Public Company Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jiangsu Dagang Co Ltd
SHE:002077
|
China | CN¥725.39 Million |
|
Jade Biosciences, Inc.
NASDAQ:JBIO
|
USA | $32.20 Million |
|
Rio Tinto PLC
LSE:RIO
|
UK | GBX58.84 Billion |
|
Sabine Royalty Trust
NYSE:SBR
|
USA | $1.43 Million |
|
Marten Transport Ltd
NASDAQ:MRTN
|
USA | $189.52 Million |
|
Rastar Environmental Protection Materials Co.Ltd.
SHE:300834
|
China | CN¥1.44 Billion |
|
Seegene Inc
KQ:096530
|
Korea | ₩226.66 Billion |
|
INVENTIVA ADS/1 O.N.
F:6IVA
|
Germany | €278.03 Million |
Liability Composition Analysis (2010–2025)
This chart breaks down Mega Lifesciences Public Company Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Mega Lifesciences Public Company Limited total assets.
Liquidity & Leverage Metrics
Mega Lifesciences Public Company Limited Total Liabilities Ratios Explained
Mega Lifesciences Public Company Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.36 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Mega Lifesciences Public Company Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Mega Lifesciences Public Company Limited (2010–2025)
The table below shows the annual total liabilities of Mega Lifesciences Public Company Limited from 2010 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ฿5.78 Billion ≈ $180.20 Million |
+33.41% |
| 2024-12-31 | ฿4.33 Billion ≈ $135.07 Million |
-16.94% |
| 2023-12-31 | ฿5.22 Billion ≈ $162.62 Million |
-11.12% |
| 2022-12-31 | ฿5.87 Billion ≈ $182.95 Million |
+11.88% |
| 2021-12-31 | ฿5.25 Billion ≈ $163.53 Million |
+13.79% |
| 2020-12-31 | ฿4.61 Billion ≈ $143.71 Million |
+5.81% |
| 2019-12-31 | ฿4.36 Billion ≈ $135.82 Million |
+11.50% |
| 2018-12-31 | ฿3.91 Billion ≈ $121.82 Million |
+12.45% |
| 2017-12-31 | ฿3.48 Billion ≈ $108.33 Million |
+6.57% |
| 2016-12-31 | ฿3.26 Billion ≈ $101.65 Million |
-0.51% |
| 2015-12-31 | ฿3.28 Billion ≈ $102.17 Million |
+19.45% |
| 2014-12-31 | ฿2.74 Billion ≈ $85.53 Million |
-3.49% |
| 2013-12-31 | ฿2.84 Billion ≈ $88.62 Million |
+13.32% |
| 2012-12-31 | ฿2.51 Billion ≈ $78.20 Million |
+27.26% |
| 2011-12-31 | ฿1.97 Billion ≈ $61.45 Million |
+43.82% |
| 2010-12-31 | ฿1.37 Billion ≈ $42.73 Million |
-- |
About Mega Lifesciences Public Company Limited
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. The company operates through three segments: Brands, Distribution, and Original Equipment Manufacture. It offers wellness and nutrition products, includi… Read more